London, 7 April 2025 - LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and world leader in neutrophil immuno-therapies, today announces the appointment of Mark A. Exley, PhD as ...

Mark brings 30 years of experience in R&D spanning discovery to late-stage clinical development London, 7 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and world ...

Mark brings 30 years of experience in R&D spanning discovery to late-stage clinical development London, 7 April 2025 - LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and ...

The TJX Companies saw a flurry of fund activity in Q4, with Puzo Michael J trimming its stake by 4.2%, joining a parade of institutions reshuffling shares like a Black Friday checkout line. TJX ...

This marks the first year of an exciting new tradition, bringing together science students and researchers from across campus to showcase and celebrate cutting-edge research. Come join us to explore ...